Acquired autoantibodies to coagulation factors
Authors:
- Peter CrowPCPeter Crow
- 1 September 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 6 (5) , 323-328
Abstract
Acquired coagulation factor antibodies are either alloantibodies or autoantibodies. Alloantibodies are formed when the body reacts to an external antigen. Commonly, alloantibodies arise when a patient who has a congenital clotting factor deficiency is infused with a blood product. Alternately, patients exposed to a coagulation protein from a different species may develop alloantibodies to the animal protein that cross-reacts with their own protein. On the other hand, autoantibodies develop spontaneously in people without pre-existing factor deficiencies and without exposure to an external antigen. These antibodies may neutralize function of a clotting factor, promote rapid clearance of a clotting factor from the blood, or alter the clotting factor in such a way that the protein-antibody complex acquires a unique function. This review focuses on recent reports of autoantibodies directed against fibrinogen, prothrombin, factor V, factor VII, factor X, and von Willebrand factor, in which these various activities of autoantibodies are illustrated.Keywords
This publication has 26 references indexed in Scilit:
- Antibodies against Fibrinogen in Pregnant Women, in Post Delivery Women and in the NewbornsThrombosis and Haemostasis, 1998
- AUTOIMMUNE COAGULATION DISORDERSRheumatic Disease Clinics of North America, 1997
- ASSOCIATION OF LUPUS ANTICOAGULANT WITH TRANSIENT ANTIBODIES TO PROTHROMBIN IN A PATIENT WITH HYPOPROTHROMBINEMIAThrombosis Research, 1997
- 9 Acquired inhibitorsBailliere's Clinical Haematology, 1996
- Factor XIII: Inherited and acquired deficiencyBlood Reviews, 1993
- Acquired factor XI inhibitor in chronic lymphocytic leukaemia.Journal of Clinical Pathology, 1992
- A Fatal Thrombotic Disorder Associated with an Acquired Inhibitor of Protein CNew England Journal of Medicine, 1987
- A Naturally Occurring Antibody That Inhibits Fibrin PolymerizationNew England Journal of Medicine, 1981
- Acquired coagulation inhibitor delaying fibrinopeptide releaseBlood, 1979
- Monoclonal IgG anticoagulants delaying fibrin aggregation in two patients with systemic lupus erythematosus (SLE)Blood, 1978